Cited by 415Liver Disease Diagnosis and TreatmentFatty Acid Research and HealthPeroxisome Proliferator-Activated Receptors

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression

Sekiya, Motohiro, Yahagi, Naoya, Matsuzaka, Takashi, Najima, Yuho, Nakakuki, Masanori, Nagai, Ryozo, Ishibashi, Shun, Osuga, Jun-ichi, Yamada, Nobuhiro, Shimano, Hitoshi·2003·Hepatology

DOI 10.1016/j.hep.2003.09.028

Open this paper in CoChat — free account

Abstract

Leptin-deficient ob/ob mice show many characteristics of obesity, including excess peripheral adiposity as well as severe hepatic steatosis, at least in part, due to increased hepatic lipogenesis. Polyunsaturated fatty acids (PUFAs) are not only ligands for peroxisome proliferator-activated receptor (PPAR) alpha but are also negative regulators of hepatic lipogenesis, which is thought to be mediated by the repression of sterol regulatory element-binding protein (SREBP)-1. We have previously shown that the disruption of SREBP-1 in ob/ob mice decreased their liver triglyceride storage. To examine whether PUFAs could reduce hepatic triglyceride deposition, we challenged ob/ob mice with dietary PUFA. It is demonstrated that PUFA markedly decreased the mature form of SREBP-1 protein and thereby reduced the expression of lipogenic genes such as fatty acid synthase (FAS) and stearoyl-CoA desaturase 1 (SCD1) in the livers of ob/ob mice. Consequently, the liver triglyceride content and plasma alanine aminotransferase (ALT) levels were decreased. Furthermore, both hyperglycemia and hyperinsulinemia in ob/ob mice were improved by PUFA administration, similar to the effect of PPARalpha activators. In conclusion, PUFAs ameliorate obesity-associated symptoms, such as hepatic steatosis and insulin resistance, presumably through both down-regulation of SREBP-1 and activation of PPARalpha.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.hep.2003.09.028

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis
Bray, G. A., & York, D. A. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.3.719 · Cited by 1,132
Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor.
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J.-Α. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 861
Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 817
Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells.
Shimomura, I., Shimano, H., Horton, J. D., Goldstein, J. L., & Brown, M. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119247 · Cited by 766

Flagged first, then by citations

Show all 39 references

Sorted by citations

Treatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez‐Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,083
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice
Guillou, H., Zadravec, D., Martin, P. G. P., & Jacobsson, A. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.12.002 · Cited by 913
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
Musso, G., Gambino, R. J., & Cassader, M. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.08.001 · Cited by 691
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044224 · Cited by 641
From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
Wree, A., Broderick, L., Canbay, A. E., Hoffman, H. M., & Feldstein, A. E. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.149 · Cited by 617
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Parker, H. M., Johnson, N. A., Burdon, C. A., Cohn, J. S., O’Connor, H. T., & George, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.018 · Cited by 569
Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance
Matsuzaka, T., Shimano, H., Yahagi, N., Kato, T., Atsumi, A., Yamamoto, T., Inoue, N., Ishikawa, M., Okada, S., Ishigaki, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1662 · Cited by 557
Causes and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 536
Polyunsaturated Fatty Acid Regulation of Gene Expression
Sessler, A. M., & Ntambi, J. M. (1998) · Journal of Nutrition · doi:10.1093/jn/128.6.923 · Cited by 427
Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study
Capanni, M., Calella, F., Biagini, M. R., Genise, S., Raimondi, L., Bedogni, G., Svegliati‐Baroni, G., Sofi, F., Milani, S., Abbate, R., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02885.x · Cited by 412
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. T. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 395
PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes
Schadinger, S. E., Bucher, N. L. R., Schreiber, B. M., & Farmer, S. R. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00513.2004 · Cited by 382
Omega-3 fatty acids in obesity and metabolic syndrome: A mechanistic update
Albracht-Schulte, K., Kalupahana, N. S., Ramalingam, L., Wang, S., Rahman, S. M., Robert-McComb, J., & Moustaid-Moussa, N. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.012 · Cited by 355
“Reduced SREBP-1c expression, via n-3 PUFA, has been attributed to inhibited transcription of nascent precursor SREBP-1c, accelerated transcript decay and reduced levels of the mature cleaved form of SREBP-1c [159,160], possibly through inhibition of proteolytic processing and reduced feed-forward activation of the Sre…”
BackgroundInfluential
Diagnosis and Therapy of Nonalcoholic Steatohepatitis
Torres, D. M., & Harrison, S. A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.077 · Cited by 359
Prostaglandins, Leukotrienes and Essential Fatty Acids
Kaur, G., Sinclair, A. J., Cameron‐Smith, D., Barr, D. P., Molero, J. C., & Konstantopoulos, N. (2009) · Cited by 321
Pathophysiology of nonalcoholic steatohepatitis.
McCullough, A. J. (2006) · PubMed · doi:10.1097/01.mcg.0000168645.86658.22 · Cited by 319
Current treatment paradigms and emerging therapies for NAFLD/NASH
Raza, S. (2020) · Frontiers in bioscience · doi:10.2741/4892 · Cited by 329
(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights
Kalupahana, N. S., Claycombe, K. J., & Moustaid-Moussa, N. (2011) · Advances in Nutrition · doi:10.3945/an.111.000505 · Cited by 305
Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence
Zelber‐Sagi, S. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i29.3377 · Cited by 307
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis
Grattagliano, I., Palmieri, V. O., Portincasa, P., Moschetta, A., & Palasciano, G. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.06.011 · Cited by 301
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
Spadaro, L., Magliocco, O., Spampinato, D., Piro, S., Oliveri, C. E., Alagona, C., Papa, G. F. S., Rabuazzo, A. M., & Purrello, F. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.003 · Cited by 296
The Mediterranean dietary pattern as the diet of choice for non‐alcoholic fatty liver disease: Evidence and plausible mechanisms
Zelber‐Sagi, S., Salomone, F., & Mlynarsky, L. (2017) · Liver International · doi:10.1111/liv.13435 · Cited by 273
Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees
Bigger, C. B., Guerra, B., Brasky, K. M., Hubbard, G. B., Beard, M. R., Luxon, B. A., Lemon, S. M., & Lanford, R. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13779-13792.2004 · Cited by 259
Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis
Tanaka, N., Sano, K., Horiuchi, A., Tanaka, E., Kiyosawa, K., & Aoyama, T. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31815591aa · Cited by 248
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Lee, K., Wu, P.-S., & Lin, H. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0237 · Cited by 269
Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma
Yahagi, N., Shimano, H., Hasegawa, K., Ohashi, K., Matsuzaka, T., Najima, Y., Sekiya, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.037 · Cited by 247
Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease
Videla, L. A., Rodrigo, R., Julia Araya, A., & Poníachik, J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.033 · Cited by 245
Polyunsaturated Fatty Acid Regulation of Gene Expression
Sampath, H., & Ntambi, J. M. (2004) · Nutrition Reviews · doi:10.1111/j.1753-4887.2004.tb00058.x · Cited by 252
Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA
González‐Périz, A., Planagumà, A., Gronert, K., Miquel, R., López‐Parra, M., Titos, E., Horrillo, R., Ferré, N., Deulofeu, R., Arroyo, V., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6250fje · Cited by 230
Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial
Argo, C. K., Patrie, J. T., Lackner, C., Henry, T. D., de Lange, E. E., Weltman, A. L., Shah, N. L., Al-Osaimi, A. M., Pramoonjago, P., Jayakumar, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.036 · Cited by 224
ChREBP: A Glucose-activated Transcription Factor Involved in the Development of Metabolic Syndrome
Iizuka, K., & Horikawa, Y. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-110 · Cited by 232
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol
Yasutake, K., Nakamuta, M., Shima, Y., Ohyama, A., Masuda, K., Haruta, N., Fujino, T., Aoyagi, Y., Fukuizumi, K., Yoshimoto, T., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802588133 · Cited by 222
An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
Pei, K., Gui, T., Kan, D., Feng, H., Jin, Y., Yang, Y., Zhang, Q., Du, Z., Gai, Z., Wu, J., et al. (2020) · BioMed Research International · doi:10.1155/2020/4020249 · Cited by 209
Omega-3 Fatty Acid Supplementation Prevents Hepatic Steatosis in a Murine Model of Nonalcoholic Fatty Liver Disease
Alwayn, I. P. J., Gura, K. M., Nosé, V., Zausche, B., Javid, P. J., Garza, J. J., Verbesey, J. E., Voss, S. D., Ollero, M., Andersson, C., et al. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000153672.43030.75 · Cited by 202
SREBPs: physiology and pathophysiology of the SREBP family
Shimano, H. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06806.x · Cited by 202
Omega 3 – Omega 6: What is right for the liver?
El‐Badry, A. M., Graf, R., & Clavien, P. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.005 · Cited by 202
Quercetin and allopurinol reduce liver thioredoxin‐interacting protein to alleviate inflammation and lipid accumulation in diabetic rats
Wang, W., Wang, C., Ding, X., Pan, Y., Gu, T., Wang, M., Liu, Y., Wang, F., Wang, S., & Kong, L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12226 · Cited by 196
Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
Edmison, J. M., & McCullough, A. J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.011 · Cited by 195
Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease
Masterton, G., Plevris, J. N., & Hayes, P. C. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04230.x · Cited by 210
Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma
Yamashita, T., Honda, M., Takatori, H., Nishino, R., Minato, H., Takamura, H., Ohta, T., & Kaneko, S. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.036 · Cited by 178
Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice
Singh, V., Chassaing, B., Zhang, L., Yeoh, B. S., Xiao, X., Kumar, M., Baker, M. T., Cai, J., Walker, R. E., Borkowski, K., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.028 · Cited by 179
Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease?: Table 1
Sartor, R. B. (2005) · Gut · doi:10.1136/gut.2004.055889 · Cited by 184
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
Minno, M. N. D. D. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i41.5839 · Cited by 175
Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations
Parker, R., Kim, S.-J., & Gao, B. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.116 · Cited by 175
Fish Oil–Based Lipid Emulsions Prevent and Reverse Parenteral Nutrition–Associated Liver Disease: The Boston Experience
de Meijer, V. E., Gura, K. M., Le, H. D., Meisel, J. A., & Puder, M. (2009) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607109332773 · Cited by 166
Pathophysiology of NASH: perspectives for a targeted treatment
Marra, F., & Lotersztajn, S. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990344 · Cited by 163
Antiobesity Effect of Eicosapentaenoic Acid in High-Fat/High-Sucrose Diet–Induced Obesity
Sato, A., Kawano, H., Notsu, T., Ohta, M., Nakakuki, M., Mizuguchi, K., Itoh, M., Suganami, T., & Ogawa, Y. (2010) · Diabetes · doi:10.2337/db09-1554 · Cited by 163
Genes or environment to determine alcoholic liver disease and non‐alcoholic fatty liver disease
Day, C. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01323.x · Cited by 162
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review
Wang, M., Ma, L., Yang, Y., Xiao, Z., & Wan, J. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1544542 · Cited by 163
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
Rives, C., Fougerat, A., Ellero‐Simatos, S., Loiseau, N., Guillou, H., Gamet‐Payrastre, L., & Wahli, W. (2020) · Biomolecules · doi:10.3390/biom10121702 · Cited by 167
Elovl2 ablation demonstrates that systemic DHA is endogenously produced and is essential for lipid homeostasis in mice
Pauter, A. M., Olsson, P., Asadi, A., Herslöf, B. G., Csikasz, R. I., Zadravec, D., & Jacobsson, A. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m046151 · Cited by 152
Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
Kersten, S. (2007) · PPAR Research · doi:10.1155/2008/132960 · Cited by 149
Fenofibrate, a peroxisome proliferator‐activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver
Harano, Y., Yasui, K., Toyama, T., Nakajima, T., Mitsuyoshi, H., Mimani, M., Hirasawa, T., Itoh, Y., & Okanoue, T. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01265.x · Cited by 148
Polyunsaturated Fatty Acids Selectively Suppress Sterol Regulatory Element-binding Protein-1 through Proteolytic Processing and Autoloop Regulatory Circuit
Takeuchi, Y., Yahagi, N., Izumida, Y., Nishi, M., Kubota, M., Teraoka, Y., Yamamoto, T., Matsuzaka, T., Nakagawa, Y., Sekiya, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.096107 · Cited by 148
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
Fougerat, A., Montagner, A., Loiseau, N., Guillou, H., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071638 · Cited by 150
Dietary Omega-3 Fatty Acid Deficiency and High Fructose Intake in the Development of Metabolic Syndrome, Brain Metabolic Abnormalities, and Non-Alcoholic Fatty Liver Disease
Simopoulos, A. P. (2013) · Nutrients · doi:10.3390/nu5082901 · Cited by 146
Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials
Zelber‐Sagi, S., Godos, J., & Salomone, F. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16638830 · Cited by 141
SREBP-1-independent regulation of lipogenic gene expression in adipocytes
Sekiya, M., Yahagi, N., Matsuzaka, T., Takeuchi, Y., Nakagawa, Y., Takahashi, H., Okazaki, H., Iizuka, Y., Ohashi, K., Gotoda, T., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700033-jlr200 · Cited by 137
Dietary Krill Oil Supplementation Reduces Hepatic Steatosis, Glycemia, and Hypercholesterolemia in High-Fat-Fed Mice
Tandy, S., Chung, R. W. S., Wat, E., Kamili, A., Berge, K., Griinari, M., & Cohn, J. S. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9016042 · Cited by 139
Novel aspects of PPARα-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study
Martin, P. G. P., Guillou, H., Lasserre, F., Dejean, S., Lan, A., Pascussi, J., Cristobal, M. S., Legrand, P., Besse, P. C., & Pineau, T. (2007) · Hepatology · doi:10.1002/hep.21510 · Cited by 136
Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial
Misciagna, G., del Pilar Díaz, M., Caramia, D. V., Bonfiglio, C., Franco, I., Noviello, M. R., Chiloiro, M., Abbrescia, D. I., Mirizzi, A., Tanzi, M., et al. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-016-0809-8 · Cited by 134
Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids
de Castro, G. S., & Calder, P. C. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.01.006 · Cited by 137
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)
Oikawa, S., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Sasaki, J., Hishida, H., Itakura, H., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.029 · Cited by 125
p53 Involvement in the Pathogenesis of Fatty Liver Disease
Yahagi, N., Shimano, H., Matsuzaka, T., Sekiya, M., Najima, Y., Okazaki, S., Okazaki, H., Tamura, Y., Iizuka, Y., Inoue, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400884200 · Cited by 125
Dietary habits and behaviors associated with nonalcoholic fatty liver disease
Yasutake, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1756 · Cited by 128
The expanding role of fish models in understanding non-alcoholic fatty liver disease
Asaoka, Y., Terai, S., Sakaida, I., & Nishina, H. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011981 · Cited by 120
Betaine Supplementation Enhances Lipid Metabolism and Improves Insulin Resistance in Mice Fed a High-Fat Diet
Du, J., Shen, L., Tan, Z., Zhang, P., Zhao, X., Xu, Y., Gan, M., Yang, Q., Ma, J., Jiang, A., et al. (2018) · Nutrients · doi:10.3390/nu10020131 · Cited by 119
Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice
Zhang, C., Chen, X., Zhu, R.-M., Zhang, Y., Yu, T., Wang, H., Zhao, H. J., Zhao, M., Ji, Y., Chen, Y., et al. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.06.002 · Cited by 118
Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors
Bordoni, A., Nunzio, M. D., Danesi, F., & Biagi, P. L. (2006) · Genes & Nutrition · doi:10.1007/bf02829951 · Cited by 117
The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease
Shapiro, H., Tehilla, M., Attal-Singer, J., Bruck, R., Luzzatti, R., & Singer, P. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.06.001 · Cited by 113
Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega‐3 fatty acids†‡
El‐Badry, A. M., Moritz, W., Contaldo, C., Tian, Y., Graf, R., & Clavien, P. (2007) · Hepatology · doi:10.1002/hep.21625 · Cited by 111
Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers
Honma, M., Sawada, S., Ueno, Y., Murakami, K., Yamada, T., Gao, J., Kodama, S., Izumi, T., Takahashi, K., Tsukita, S., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0062-9 · Cited by 108
Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome
Libby, A. E., Bales, E. S., Orlicky, D. J., & McManaman, J. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.759795 · Cited by 111
Mouse Elovl-6 promoter is an SREBP target
Kumadaki, S., Matsuzaka, T., Kato, T., Yahagi, N., Yamamoto, T., Okada, S., Kobayashi, K., Takahashi, A., Yatoh, S., Suzuki, H., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.075 · Cited by 103
Altered hepatic expression of SREBP-1 and PPARγ is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients
Lemoine, M., Barbu, V., Girard, P. M., Kim, M. J., Bastard, J., Wendum, D., Paye, F., Housset, C., Capeau, J., & Serfaty, L. (2006) · AIDS · doi:10.1097/01.aids.0000206503.01536.11 · Cited by 105
Palmitate Impairs and Eicosapentaenoate Restores Insulin Secretion Through Regulation of SREBP-1c in Pancreatic Islets
Kato, T., Shimano, H., Yamamoto, T., Ishikawa, M., Kumadaki, S., Matsuzaka, T., Nakagawa, Y., Yahagi, N., Nakakuki, M., Hasty, A. H., et al. (2008) · Diabetes · doi:10.2337/db06-1806 · Cited by 103
Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice
Shang, T., Liu, L., Zhou, J., Zhang, M., Hu, Q., Fang, M., Wu, Y., Yao, P., & Gong, Z. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0461-2 · Cited by 106
N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced trans-activating capacity of LXRα
Howell, G., Deng, X., Yellaturu, C., Park, E. A., Wilcox, H. G., Raghow, R., & Elam, M. B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.08.008 · Cited by 103
Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice
Yin, H.-Q., Kim, M., Kim, J. H., Kong, G., Kang, K., Kim, H., Yoon, B.-I., Lee, M., & Lee, B. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.06.018 · Cited by 97
Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis
Lelliott, C. J., López, M., Curtis, R. K., Parker, N., Laudes, M., Yeo, G. S. H., Jimenez‐Liñan, M., Grosse, J., Saha, A. K., Wiggins, D. K., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3196com · Cited by 94
Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats
Hussein, O. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i3.361 · Cited by 93
Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease
de Oliveira, C. P. M. S., Coelho, A. M. M., Barbeiro, H. V., de Lima, V. M. R., Soriano, F. G., RIBEIRO, C. F. D. S., Molan, N. A., Alves, V. A. F., de Souza, H. P., Machado, M. C. C., et al. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000200004 · Cited by 94
Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets
Pachikian, B. D., Essaghir, A., Demoulin, J., Neyrinck, A. M., Catry, É., Backer, F. C. D., Dejeans, N., Dewulf, E. M., Sohet, F. M., Portois, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023365 · Cited by 91
Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice
Ishii, H., Horie, Y., Ohshima, S., Anezaki, Y., Kinoshita, N., Dohmen, T., Kataoka, E., Sato, W., Goto, T., Sasaki, J., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.031 · Cited by 90
New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis
Pydyn, N., Miękus, K., Jura, J., & Kotlinowski, J. (2020) · Pharmacological Reports · doi:10.1007/s43440-019-00020-1 · Cited by 89
Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition*
Wang, Y., Torres‐Gonzalez, M., Tripathy, S., Botolin, D., Christian, B., & Jump, D. Β. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800123-jlr200 · Cited by 87
The role of n − 6 and n − 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease
Monteiro, J., Leslie, M. A., Moghadasian, M. H., Arendt, B. M., Allard, J. P., & David, W. L. (2014) · Food & Function · doi:10.1039/c3fo60551e · Cited by 84
Perspectives on Treatment for Nonalcoholic Steatohepatitis
Lassailly, G., Caiazzo, R. J., Pattou, F. N., & Mathurin, P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.004 · Cited by 87
ASH and NASH
Scaglioni, F., Ciccia, S., Marino, M., Bedogni, G., & Bellentani, S. (2011) · Digestive Diseases · doi:10.1159/000323886 · Cited by 79
[Molecular mechanisms of action and health benefits of polyunsaturated fatty acids].
Rodríguez‐Cruz, M., Tovar, A. R., Prado, M. D., & Torres, N. (2005) · PubMed · Cited by 79
Dietary α-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via ameliorating lipid homeostasis at adipose tissue-liver axis in mice
Wang, M., Zhang, X., Feng, K., He, C., Li, P., Yuanjia, H., Su, H., & Wan, J. (2016) · Scientific Reports · doi:10.1038/srep26826 · Cited by 80
Dietary Genistein Alleviates Lipid Metabolism Disorder and Inflammatory Response in Laying Hens With Fatty Liver Syndrome
Lv, Z., Xing, K., Li, G., Liu, D., & Guo, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01493 · Cited by 81
Transcriptional Regulation of Hepatic Fatty Acid Metabolism
Guillou, H., Martin, P. G. P., & Pineau, T. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_1 · Cited by 80
Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice
Tanaka, N., Zhang, X., Sugiyama, E., Kono, H., Horiuchi, A., Nakajima, T., Kanbe, H., Tanaka, E., Gonzalez, F. J., & Aoyama, T. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.031 · Cited by 78
Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease
Boyraz, M., Pirgon, Ö., Dündar, B. N., Çekmez, F., & Hatipoğlu, N. (2015) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1749 · Cited by 80
Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase
Deng, X., Dong, Q., Bridges, D., Raghow, R., Park, E. A., & Elam, M. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.08.007 · Cited by 76
Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines
huang, L.-L., Wan, J., Wang, B., He, C., Ma, H., LI, T. W., & Kang, J. X. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.02.002 · Cited by 76
Activation of PPARα and PPARγ reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1
König, B., Koch, A. H., Spielmann, J., Hilgenfeld, C., Hirche, F., Stangl, G. I., & Eder, K. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.009 · Cited by 75

Authors: Sekiya, M., Yahagi, N., Matsuzaka, T., Najima, Y., Nakakuki, M., Nagai, R., Ishibashi, S., Osuga, J.-I., Yamada, N., & Shimano, H.
Affiliations: The University of Tokyo (JP)
University of Tsukuba (JP)
Corresponding author: Shimano, Hitoshi
ORCID: Sekiya, Motohiro
Yahagi, Naoya
Matsuzaka, Takashi
Najima, Yuho
Nagai, Ryozo
Ishibashi, Shun
Shimano, Hitoshi
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2003-12
Volume: 38
Issue: 6
Pages: 1529-1539
ISSN: 0270-9139 (ISSN-L)
DOI: 10.1016/j.hep.2003.09.028
OpenAlex: W2079378050
Cited by: 415
References: 39
Citations by year: 2026: 2 · 2025: 4 · 2024: 12 · 2023: 21 · 2022: 12 · 2021: 17 · 2020: 24 · 2019: 12 · 2018: 16 · 2017: 21 · 2016: 23 · 2015: 25 · 2014: 19 · 2013: 34 · 2012: 17
FWCI: 9.29
Type: journal article
Language: en
Open access: closed
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 4292 d)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords: polyunsaturated fatty acids, hepatic steatosis, SREBP1, PPARα, leptin-deficient ob/ob mice, hepatic lipogenesis, fatty acid synthase, stearoyl-CoA desaturase 1, insulin resistance, hyperinsulinemia, hyperglycemia, obesity
MeSH terms: Alanine Transaminase, Animals, Cholesterol, DNA-Binding Proteins, Fatty Acids, Unsaturated, Fatty Liver, Gene Expression Regulation, Insulin Resistance, Liver, Mice, Inbred C57BL, Mice, Obese, Transcription Factors, Triglycerides, Receptors, Cytoplasmic and Nuclear, CCAAT-Enhancer-Binding Proteins, Mice, Sterol Regulatory Element Binding Protein 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks